Table 1. Are mutations in other genes subject to germline selection?
Relevant references are given in the main text. FGFR2 and FGFR3-members of the fibroblast growth factor receptor family. RET-rearranged during transfection protooncogene. MEN2B-Multiple Endocrine Neoplasia type 2B. MECP2-member of the methyl-CpG-binding protein family.
| Disease | Recurrent sporadic nucleotide substitution | Mode of transmission | Gene | Unexpected “high” mutation frequency | Virtually exclusive paternal origin | Paternal age effect | Direct testis analysis |
|---|---|---|---|---|---|---|---|
| Apert Syndrome | 755C>G 758C>G |
Dominant | FGFR2 | Yes | Yes | Yes | Yes |
| Achondro plasia | 1138G>A | Dominant | FGFR3 | Yes | Yes | Yes | Partial |
| MEN2B | 2943T>C | Dominant | RET (protooncogene) | Possibly | Yes | Yes | No |
| Rett Syndrome | Recurrent mutations at 8 CpG sites | X-linked (only females affected) | MECP2 | Possibly | Yes | Weak | No |